You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


NHS fast-tracks new targeted drug for rare lung cancer

A new targeted drug for a rare and aggressive form of lung cancer will be fast-tracked to eligible patients within weeks – making patients in England the first in Europe to access mobocertinib.